VISTN Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA

Oslo, Norway, 22 May 2025

In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 22th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 5 156 012 shares in the Company at the AGM, corresponding to 11.63% of the total number of votes and shares in the Company. Together with the 14 509 280 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 19 665 292 votes at the AGM, corresponding to a total of 44,35% of the total number of shares and votes in the Company. The proxies are only valid for the AGM and will lapse thereafter.



EN
22/05/2025

Underlying

VISTNVistin Pharma ASA

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Vistin Pharma ASA

 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Minutes from the annual general meeting 2025

Vistin Pharma ASA: Minutes from the annual general meeting 2025 Oslo, Norway, 22 May 2025 Vistin Pharma ASA (OSE: VISTN), please find attached the minutes from the annual general meeting held today, on the 22 May 2025. For further information, please contact: Alexander KarlsenCFO+47 97 05 36 21 This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act. Attachment

9h / 48m 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Disclosure of voting rights at AGM in Vistin Pharma ASA

Disclosure of voting rights at AGM in Vistin Pharma ASA Oslo, Norway, 22 May 2025 In relation to the Annual General Meeting in Vistin Pharma ASA (OSE: VISTN), on the 22th of May, the Company's Chair of the Board, Øyvin Brøymer, has received open proxies to represent a total of 5 156 012 shares in the Company at the AGM, corresponding to 11.63% of the total number of votes and shares in the Company. Together with the 14 509 280 shares held by Øyvin Brøymer through Intertrade Shipping AS, he will represent a total of 19 665 292 votes at the AGM, corresponding to a total of 44,35% of the tota...

12h / 51m 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA (VISTN): Update from the Election Committee

Vistin Pharma ASA (VISTN): Update from the Election Committee Oslo, Norway, 07 May 2025 The Election Committee has received a request from Øystein Stray Spetalen that he does not want to be re-elected as a board member of Vistin Pharma ASA. The Election Committee has therefore assessed the consequences of this for the recommendation submitted 13 March 2025 to this year's annual general meeting. Øystein Spetalen was the only board member up for election, and it was recommended that he was re-elected. The composition of the board's expertise has been assessed, and it has been investigated w...

May 7, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclos...

Vistin Pharma ASA (VISTN): Mandatory notification of trade and disclosure of large shareholding Ferncliff Listed Dai AS has on 6 May 2025 sold 1,234,280 shares in Vistin Pharma ASA at NOK 22.50 per share. Saga Pure ASA has on 6 May 2025 sold 700,000 shares in Vistin Pharma ASA at NOK 22.50 per share. After the transaction Saga Pure ASA and Ferncliff Listed Dai AS has no holding of shares in Vistin Pharma ASA. Øystein Stray Spetalen and associated parties have a holding of 331,886 shares in Vistin Pharma ASA. Saga Pure ASA and Ferncliff Listed Dai AS are closely associated with board mem...

May 6, 2025 1 EN
 PRESS RELEASE
Free
VISTN Vistin Pharma A...

Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025

Vistin Pharma ASA: Notice of Annual General Meeting 22 May 2025 Oslo, Norway, 29 April 2025 Vistin Pharma ASA (OSE: VISTN), please find attached the call for the Annual General Meeting in Vistin Pharma, to be held on 22 May 2025 at 13:00 CEST. A physical Annual General Meeting will not be held. Instead, shareholders should authorize the Chairman of the Board. It is possible to give proxy with and without voting instructions. By using a proxy with voting instructions, the shareholders will vote on the specific issues without personal attendance. For further information on the use of prox...

April 29, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch